A phase Ib multiple dose study evaluating TTP-273 in patients with type 2 diabetes not controlled on metformin

Trial Profile

A phase Ib multiple dose study evaluating TTP-273 in patients with type 2 diabetes not controlled on metformin

Completed
Phase of Trial: Phase I

Latest Information Update: 12 May 2016

At a glance

  • Drugs TTP 273 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 12 May 2016 Data from this trial were presented at the Keystone Symposia on New Therapeutics for Diabetes and Obesity 2016, according to a vTv Therapeutics LLC media release.
    • 20 Apr 2016 Data will be presented at the Keystone Symposia on New Therapeutics for Diabetes and Obesity 2016, according to a vTv Therapeutics LLC media release.
    • 22 Feb 2016 Results presented at the Keystone Symposia on G-Protein Coupled Receptors: Structure, Signaling and Drug Discovery 2016, according to a vTv Therapeutics LLC media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top